0
0
30 words
0
Comments
Amidst steep competition, GSK’s Arexvy becomes the first approved RSV vaccine worldwide for preventing RSV in older adults.
You are the first to view
http://www.pharmaceutical-technology.com/news/fda-grants-gsk-first-ever-approval-for-rsv-vaccine/
Create an account or login to join the discussion